Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds: Novel metabolites in rat urine following injection of α-methylfentanyl, one of the most abused typical designer drugs

Journal of Health Science

Volumn 54, Issue 6, 2008, Pages 629-637

  Higashikawa, Yoshiyasu ^a   Suzuki, Shinichi ^a  

^a NATIONAL RESEARCH INSTITUTE OF POLICE SCIENCE   (Japan)

Author keywords

methylfentanyl; Designer drug; Forensic; GC MS; Metabolite

Indexed keywords

ALPHA METHYLFENTANYL; DESIGNER DRUG; FENTANYL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL STRUCTURE; DRUG ABUSE; DRUG DEPENDENCE; FATALITY; GAS CHROMATOGRAPHY; MALE; MASS SPECTROMETER; METABOLITE; NONHUMAN; RAT; STRUCTURE ANALYSIS; SYNTHESIS; URINALYSIS;

RATTUS;

EID: 57349109981     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.54.629     Document Type: Article

References (22)

1. Stinson, S. (1981) Structure of bogus "China White" solved. Chem. Eng. News, 19, 71-72.
2. Kram, T. C., Cooper, D. A. and Allen, A. C. (1981) Behind the identification of China White. Anal. Chem., 53, 1379A-1386A.
3. Cheng, M. T., Kruppa, G. H. and McLafferty, F. W. (1982) Structural information from tandem mass spectrometry for China White and related fentanyl derivatives. Anal. Chem., 54, 2204-2207.
4. Baum, R. M. (1985) New variety of street drugs poses growing problem. Designer drugs - analogs of compounds with proven pharmacological activity made by underground chemists - present novel challenges to law enforcement officials, legislators, and scientists. Chem. Eng. News, 9, 7-16.
5. Shafer, J. (1985) Designer drugs. Science, 85, 60-67.
6. Cooper, D. A, Jacob, M. and Allen, A. C. (1986) Identification of fentanyl derivatives. J. Forensic Sci., 31, 511-528.
7. Suzuki, S., Inoue, T. and Kashima, C. (1986) Studies on 1-(2-phenethyl)-4-(N-propionylanilino) piperidine (fentanyl) and related compounds. I. Spectroscopic and chromatographic analysis of 3-methylfentanyl and α-methylfentanyl. Chem. Pharm. Bull. (Tokyo), 34, 1340-1343.
8. Suzuki, S. (1989) Studies on fentanyl and related compounds. II. Spectrometric discrimination of five mono methylated fentanyl isomers by gas chromatography/ Fourier transform-infrared spectrometry. Forensic Sci. Int., 43, 15-19.
9. Suzuki, S., Tsuchihashi, H. and Arimoto, H. (1989) Studies on 1-(2-phenethyl)-4-(N-propionylanilino) piperidine (fentanyl) and related compounds. III. Effect of methyl group introduction into fentanyl on sensitivity enhancement in gas chromatography with surface ionization detection. J. Chromatogr. A, 475, 400-403.
10. Ohta, H., Suzuki, S. and Ogasawara, K. (1999) Studies on fentanyl and related compounds. IV. Chromatographic and spectrometric discrimination of fentanyl and its derivatives. J. Anal. Toxicol., 23, 280-285.
11. Van Wijngaarden, I. and Soudijn, W. (1968) The metabolism and excretion of the analgesic fentanyl (R 4263) by Wistar rats. Life Sci., 7, 1239-1244.
12. Maruyama, Y. and Hosoya, E. (1969) Studies on the fate of fentanyl. Keio J. Med., 18, 59-70.
13. Goroumaru, T., Furuta, T., Baba, S., Yoshimura, N., Miyawaki, T., Sameshima, T. and Miyao, J. (1981) Metabolism of fentanyl in rats and man. Anesthesiology, 55, A173.
14. National Police Agency (2006) White Paper on Police (Annual report of police activities in Japan), Government of Japan.
15. Van Rooy, H. H., Vermeulen, N. P. E. and Bovill, J. G. (1983) The assay of fentanyl and its metabolites in plasma of patients using gas chromatography with alkali flame ionization detection and gas chromatography-mass spectrometry. J. Chromatogr. B, 223, 85-93.
16. Goroumaru, T., Matsuura, H., Furuta, T., Baba, S., Yoshimura, N., Miyawaki, T. and Sameshima, T. (1982) Identification of fentanyl metabolites in rat urine by gas chromatography-mass spectrometry with stable-isotope tracers. Drug Metab. Dispos., 10, 542-546.
17. Goroumaru, T., Matsuura, H., Yoshimura, N., Miyawaki, T., Sameshima, T., Miyao, J., Furuta, T. and Baba, S. (1984) Identification and quantitative determination of fentanyl metabolites in patients by gas chromatography-mass spectrometry. Anesthesiology, 61, 73-77.
18. Goroumaru, T., Katashima, K., Matsuura, H. and Yoshimura, N. (1985) Metabolismof fentanyl in isolated hepatocytes from rat and guinea pig. Chem. Pharm. Bull. (Tokyo), 33, 3922-3928.
19. Feierman, D. E. and Lasker, J. M. (1996) Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4. Drug. Metab. Dispos., 24, 932-939.
20. Labroo, R. B., Paine, M. F., Thummel, K. E. and Kharasch, E. D. (1997) Fentanyl metabolism by human hepatic and intestinal cytochrome P-450 3A4: implications for interindividual variability in disposition, efficacy and drug interactions. Drug Metab. Dispos., 25, 1072-1080.
21. Schuttler, J. and White, P. F. (1984) Optimization of the radioimmunoassays for measuring fentanyl and alfentanil in human serum. Anesthesiology, 61, 315-320.
22. Higashikawa, Y. and Suzuki, S. (2008) Studies on 1-(2-phenethyl)-4-(N- propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicology, 26, 1-5.